MTOR and neoplasm: Among them, it induces the epithelial–mesenchymal transition (EMT) into non-tumour epithelial cells though the activation of mTOR and PI3K pathways, leading to the apoptosis resistance of cancer cells, and thereby promoting the trans-differentiation of CAFs.